Hobart Private Capital, LLC Bristol Myers Squibb CO Transaction History

Hobart Private Capital, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Mar 11, 2024	SELL	$53.63 - $62.52 $590,573 - $688,470	-11,012 Closed	0 $0
Q3 2021 Mar 11, 2024	SELL	$59.17 - $69.31 $31,360 - $36,734	-530 Reduced 4.59%	11,012 $652 Million
Q2 2021 Mar 11, 2024	SELL	$61.91 - $67.42 $138,430 - $150,751	-2,236 Reduced 16.23%	11,542 $771 Million
Q1 2021 Mar 11, 2024	BUY	$59.34 - $66.74 $817,586 - $919,543	13,778 New	13,778 $870 Million
Q4 2020 Mar 11, 2024	SELL	$57.74 - $65.43 $21,306 - $24,143	-369 Reduced 2.36%	15,258 $946 Million
Q3 2020 Mar 11, 2024	BUY	$57.43 - $63.64 $746 - $827	13 Added 0.08%	15,627 $942 Million
Q2 2020 Mar 11, 2024	BUY	$54.82 - $64.09 $277,389 - $324,295	5,060 Added 47.94%	15,614 $918 Million
Q1 2020 Mar 11, 2024	BUY	$46.4 - $67.43 $41,713 - $60,619	899 Added 9.31%	10,554 $588 Million
Q4 2019 Mar 11, 2024	BUY	$49.21 - $64.19 $475,122 - $619,754	9,655 New	9,655 $620 Million
Q3 2019 Mar 11, 2024	BUY	$42.77 - $50.71 $16,551 - $19,624	387 Added 4.66%	8,686 $440 Million
Q2 2019 Mar 11, 2024	BUY	$44.62 - $49.34 $40,381 - $44,652	905 Added 12.24%	8,299 $376 Million
Q1 2019 Mar 11, 2024	SELL	$45.12 - $53.8 $143,165 - $170,707	-3,173 Reduced 30.03%	7,394 $353 Million
Q4 2018 Mar 11, 2024	BUY	$48.76 - $63.23 $205,084 - $265,945	4,206 Added 66.12%	10,567 $549 Million
Q3 2018 Mar 11, 2024	BUY	$55.19 - $62.25 $351,063 - $395,972	6,361 New	6,361 $395 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $122B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Hobart Private Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Hobart Private Capital, LLC with notifications on news.